论文信息 - High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals - 字舞流文

High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals

E. Schiff | K. Reddy | R. Chung | P. Kwo | K. Kowdley | E. Gane | H. Dvory‐Sobol | D. Pound | D. Brainard | J. McHutchison | I. Jacobson | E. Lawitz | M. Nguyen | Jenny C. Yang | R. Herring | D. An | R. Nahass | Z. Younes | L. Stamm | M. Curry | T. Tran | N. Reau | K. Etzkorn | F. Hinestrosa | M. Davis | M. Rodríguez-Torres | M. Bennet